Protocells: Modular Mesoporous Silica Nanoparticle-Supported Lipid Bilayers for Drug Delivery. - Wikidata - awgldk - TriplyDB

Protocells: Modular Mesoporous Silica Nanoparticle-Supported Lipid Bilayers for Drug Delivery.

Protocells: Modular Mesoporous Silica Nanoparticle-Supported Lipid Bilayers for Drug Delivery.

http://www.wikidata.org/entity/Q37134029

about

Enhanced Blood Suspensibility and Laser-Activated Tumor-specific Drug Release of Theranostic Mesoporous Silica Nanoparticles by Functionalizing with Erythrocyte Membranes.Boronic Acid as Glucose-Sensitive Agent Regulates Drug Delivery for Diabetes Treatment A novel approach for targeted delivery to motoneurons using cholera toxin-B modified protocells.Electric double layer electrostatics of lipid-bilayer-encapsulated nanoparticles: Toward a better understanding of protocell electrostatics.Mesoporous Silica and Organosilica Nanoparticles: Physical Chemistry, Biosafety, Delivery Strategies, and Biomedical Applications.Mesoporous Silica Nanoparticles for Drug Delivery: Current Insights.TPGS-Functionalized Polydopamine-Modified Mesoporous Silica as Drug Nanocarriers for Enhanced Lung Cancer Chemotherapy against Multidrug Resistance.Understanding the Connection between Nanoparticle Uptake and Cancer Treatment Efficacy using Mathematical Modeling.Lipid-Coated Mesoporous Silica Nanoparticles for the Delivery of the ML336 Antiviral to Inhibit Encephalitic Alphavirus Infection

P2860

Q36296097-C0DAB534-460F-4F71-BC3C-77670AD3B7D3 Q38647443-73ED6CA6-7998-4640-AEF0-80F03F985792 Q41542370-94B11F56-B078-4896-AB1C-D644B47E3762 Q47254423-4338BCCC-E943-43D5-A1D4-3F587C69C7E4 Q47295411-47BF5768-488F-4E10-923E-1395F3784C53 Q50163907-698E7551-3273-4132-A881-E294CECED12C Q50847783-7F5D0EDB-00F7-4CD7-AD47-2552CCD29E70 Q55383999-F91F1DA1-C645-42F8-AF36-FDAB9555CFD5 Q58726168-73BD9E1D-26E1-4119-84A0-8A8F88AA05A1

P2860

Protocells: Modular Mesoporous Silica Nanoparticle-Supported Lipid Bilayers for Drug Delivery.

http://www.wikidata.org/entity/Q37134029

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 18 January 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Protocells: Modular Mesoporous ...... id Bilayers for Drug Delivery.

@en

Protocells: Modular Mesoporous ...... id Bilayers for Drug Delivery.

@nl

type

label

Protocells: Modular Mesoporous ...... id Bilayers for Drug Delivery.

@en

Protocells: Modular Mesoporous ...... id Bilayers for Drug Delivery.

@nl

prefLabel

Protocells: Modular Mesoporous ...... id Bilayers for Drug Delivery.

@en

Protocells: Modular Mesoporous ...... id Bilayers for Drug Delivery.

@nl

P1433

Q37134029-A56A605C-8570-40ED-A4CD-E85A66AD9828

P1476

Q37134029-8FF8FE24-506D-4511-B4AD-E9C06AD3B003

P2093

Q37134029-17979904-C173-45F7-A8E5-5D94C9241894

Q37134029-52BD6ACE-7BDE-4E4D-A0EA-C5E154E44559

Q37134029-81BBCE55-399C-47B6-878F-5C683C0BDD2C

Q37134029-F448A8F6-D461-46E8-BFC0-9ED6E7840878

Q37134029-FD4A3269-838D-42F7-8F3E-60DFE903541E

P2860

Q37134029-01BEACEF-FF6F-4CBF-9AC6-CA4EBBB7CAAE

Q37134029-01F3DF51-F957-4CA1-A339-072A78B3A341

Q37134029-03005F06-771D-458D-BFBF-86AB174FB8EF

Q37134029-041FEE3D-A57D-4F60-9C45-A292ABCE1755

Q37134029-09C774F2-F0F3-4E02-ACC3-F3F3E40B5363

Q37134029-0C5C6D64-8E58-4BAA-AB67-D102163D1AF1

Q37134029-1181B96A-37C5-43CC-9052-41482C3A01B7

Q37134029-13C75567-4419-429F-A492-9631E30413ED

Q37134029-1681466B-CA8C-42D7-8EFC-7B6543F9F882

Q37134029-16EC8AB4-C439-480A-ACC2-FD4425D1F096

P304

Q37134029-62D8CEF6-286E-41E5-8B99-C03472973EC4

P31

Q37134029-76EBC779-7A6D-4590-8057-5F6691E955F5

P356

Q37134029-BF0DA7C3-B8DD-4895-8906-712781995AB0

P433

Q37134029-B24FB6F4-1800-4805-A63F-4B56A036E6C2

P478

Q37134029-F8AEA8F7-978A-4570-B1A9-D383ECC45925

P50

Q37134029-E66093C5-5F3B-432E-81CB-82A83C7C9C47

P577

Q37134029-C153362D-6D41-4A81-9070-8E21E0242DDE

P698

Q37134029-B5293BB3-300B-4F1C-971E-A4FC5A16B608

P921

Q37134029-182A8111-CE9B-42C6-9AE8-2A5D0ADE85DB

Q37134029-21392F15-630D-4F82-B8F0-04DE451BE1FB

P932

Q37134029-3C4B476A-2EA5-4864-8B07-A17A4FC7F22F

P356

P1433

P1476

Protocells: Modular Mesoporous ...... id Bilayers for Drug Delivery.

@en

P2093

C Jeffrey Brinker

http://www.w3.org/2001/XMLSchema#string

Carlee E Ashley

http://www.w3.org/2001/XMLSchema#string

Christophe Theron

http://www.w3.org/2001/XMLSchema#string

Eric C Carnes

http://www.w3.org/2001/XMLSchema#string

Paul N Durfee

http://www.w3.org/2001/XMLSchema#string

P2860

Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform

Synthetic protocells interact with viral nanomachinery and inactivate pathogenic human virus

Mesoporous silica nanoparticle nanocarriers: biofunctionality and biocompatibility

Biocompatible mesoporous silica nanoparticles with different morphologies for animal cell membrane penetration

Nanoparticle therapeutics: an emerging treatment modality for cancer

Nanocarriers as an emerging platform for cancer therapy

Recent advances with liposomes as pharmaceutical carriers

Aspect ratio determines the quantity of mesoporous silica nanoparticle uptake by a small GTPase-dependent macropinocytosis mechanism.

In vivo biodistribution and clearance studies using multimodal organically modified silica nanoparticles.

Steric confinement of proteins on lipid membranes can drive curvature and tubulation.

P304

2173-2185

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/SMLL.201502119

http://www.w3.org/2001/XMLSchema#string

P433

16

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P50

Kimberly S Butler

P577

2016-01-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26780591

http://www.w3.org/2001/XMLSchema#string

P921

P932

4964272

http://www.w3.org/2001/XMLSchema#string